πŸ‡ΊπŸ‡Έ FDA
Patent

US 8962835

Imidazopyrazine Syk inhibitors

granted A61KA61K9/0053A61P

Quick answer

US patent 8962835 (Imidazopyrazine Syk inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Feb 24 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K9/0053, A61P, A61P1/00, A61P11/00